Cera Sanitaryware Limited share price
NSE: CERA · ISIN INE739E01017
Key numbers
- Market cap
- ₹ 6,959 Cr
- Current price
- ₹ 5,396.50
- 52-week high / low
- ₹ 6,740 / 4,461
- Stock P/E
- 34.4
- Book value
- ₹ 1,141.6
- Dividend yield
- 1.39%
- ROCE
- 18.8%
- ROE
- 14.5%
- Debt to equity
- 0.03
- Sales growth (3 yrs)
- 4.1%
- Profit growth (3 yrs)
- -0.8%
- 1-year return
- -12.7%
About Cera Sanitaryware Limited
Cera Sanitaryware Limited manufactures, sells, and trades in building material products in India. The company offers sanitaryware, including toilets, wash basins, cisterns, seat covers, and fittings; faucets, showers, health faucets, allied products, and bath accessories; urinals; special needs bathroom products, shower chairs, and grab bars and handrails; green bathroom products; floor and wall tiles; shower partitions; kitchen sinks; bathtubs; and vanity cabinets and mirrors under the Senator, CERA Luxe, CERA, and Polipluz brands. It also exports its products. The company serves individual homeowners, small-scale buyers, construction companies, real estate developers, government bodies, and large entities through dealer and sub-dealer networks and direct engagement channels. The company was formerly known as Madhusudan Oils & Fats Ltd and changed its name to Cera Sanitaryware Limited in January 2003. Cera Sanitaryware Limited was founded in 1980 and is headquartered in Ahmedabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 407 | 488 | 499 | 644 | 486 |
| Operating profit | 53 | 67 | 51 | 98 | 49 |
| Net profit | 47 | 57 | 24 | 77 | 45 |
| EPS (₹) | 36.08 | 43.92 | 18.35 | 59.96 | 35.13 |
Concall summary (2026-08-12)
AI summary of the earnings call transcript · tone: Positive · source document
Guidance & outlook
- Supported by improving demand conditions, a strong balance sheet, continued investments in strengthening digital and channel capabilities, we remain confident of sustaining our growth momentum and maintaining our FY27 revenue growth guidance of 18% to 20%.
- EBITDA margins stood at 10.1% in Q1 FY27 as compared to 13.1 in Q1 FY26.
Growth & demand
- On a Y-o-Y basis, sanitaryware revenue grew by 14%, Faucetware by 25%, tiles by 22%, and Wellness declined by 7%.
- If I have to give a breakup of the total growth, in case of Sanitaryware, we saw 14% growth, which was largely driven by volume, with volume contributing around 10%, and price contribut ing around 2%.
Margins & costs
- Following the pricing revisions undertaken during March and May 2026, cumulative price increases now stand at approximately 12% in Sanitaryware and 16% in Faucetware.
- EBITDA excluding other income for the quarter stood at INR 49.2 crore as compared to INR 53.1 crore in the corresponding quarter of the previous year.
Capex & expansion
- Capacity utilization during the quarter stood at 61% for sanitaryware and 96% for Faucetware.
- Q1 FY27 Earnings Call Page 5 of 14 For FY27, we have planned a capital expenditure outlay of approximately INR 43 crore.
Balance sheet & cash
- From an industry perspective, the challenges across the operating landscape are creating a differentiated environment with larger, more established players being able to leverage their scale and set up to deliver more efficient operations.
- This reduces the turnover but does not have any impact on absolute profitability or cash flows of the Company.
Peers in Building Products & Equipment
Data for information only, not investment advice. Prices end of day.